Sumitomo Pharma Oncology, Inc. H-1B wage filings

Marlborough, MA. Last filed in fiscal 2023. Figures cover every filing since fiscal 2020; none in the latest 12 months reach five.

Sumitomo Pharma Oncology, Inc. filed 5 wage applications for H-1B and similar visas from fiscal 2022 to fiscal 2023. The median wage it offered was $114,298, 34.2% above the government's prevailing wage for the same jobs.

Filings since FY2022
5
Positions covered
5
Certified
100.0%
Job titles
5
Worksite cities
2
Last filed
FY2023

Offered wage since 2022

Sumitomo Pharma Oncology, Inc. made 5 filings across 2 fiscal years since 2022, too few in most years to track the wage year by year. Its busiest full year was fiscal 2023, with 4 filings.

Fiscal years run October to September.

Sumitomo Pharma Oncology, Inc. by fiscal year

Fiscal yearFilingsMedian offeredvs year beforeMedian prevailingvs prevailing
20234$131,412n/a$110,043+28.2%
20221n/an/an/an/a

Offered wage by job title

Middle half of offered wagesMedian offered wageMedian prevailing wage

Job titleFilingsMedian offeredOffered range and prevailing wagevs prevailing
Associate Director, Pharmacovigilance Systems1$166,036+22.2%
Clinical Data Manager1$106,745+62.3%
Manager, Quality Management Systems1$114,298+54.1%
Scientist I - Translational Biology1$109,408at the minimum
Sr. Manager, Accounting1$148,526+34.2%

Where the jobs are

WorksiteFilingsMedian offered
Marlborough, MA4$131,412
Suite, UT1$109,408

By visa type: 4 H-1B, 1 E-3 (Australia). By outcome: 5 certified.

Seniority of the jobs filed

Level I, entry20%
Level II, qualified20%
Level III, experienced20%
Level IV, fully competent40%

The government assigns each job one of four wage levels. A higher level means a higher legal minimum.

What these numbers are

Source: U.S. Department of Labor, OFLC disclosure data. How we clean and count it.

Other employers based in Marlborough, MA